We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 7867I
GlaxoSmithKline PLC
21 June 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mrs V A Whyte === ======================== =========================================== b) Position/status Company Secretary === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each "Ordinary the financial Shares" instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the The exercise of options over 4,820 Ordinary transaction Shares, granted on 19 February 2008 under the GlaxoSmithKline 2001 Share Option Plan - UK Unapproved Trust. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP11.47 4,820 ---------- ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2017-06-20 === ======================== =========================================== f) Place of the n/a transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mrs V A Whyte === ======================== =============================================== b) Position/status Company Secretary === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of Ordinary shares of 25 pence each "Ordinary the financial Shares" instrument ISIN: GB0009252882 === ======================== =============================================== b) Nature of the The sale of 4,820 Ordinary Shares following transaction the exercise of options granted on 19 February 2008 under the GlaxoSmithKline 2001 Share Option Plan - UK Unapproved Trust. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.93 4,820 ---------- ---------- === ======================== =============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =============================================== e) Date of the transaction 2017-06-20 === ======================== =============================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXFLFLDQFXBBZ
(END) Dow Jones Newswires
June 21, 2017 09:35 ET (13:35 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions